Treatment for Refractory Pruritus Using Oral Aprepitant
- PMID: 26848236
- PMCID: PMC4737822
- DOI: 10.5021/ad.2016.28.1.124
Treatment for Refractory Pruritus Using Oral Aprepitant
Figures
References
-
- Lotts T, Ständer S. Research in practice: substance P antagonism in chronic pruritus. J Dtsch Dermatol Ges. 2014;12:557–559. - PubMed
-
- Santini D, Vincenzi B, Guida FM, Imperatori M, Schiavon G, Venditti O, et al. Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study. Lancet Oncol. 2012;13:1020–1024. - PubMed
-
- Booken N, Heck M, Nicolay JP, Klemke CD, Goerdt S, Utikal J. Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma. Br J Dermatol. 2011;164:665–667. - PubMed
-
- Vincenzi B, Tonini G, Santini D. Aprepitant for erlotinib-induced pruritus. N Engl J Med. 2010;363:397–398. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
